Monday Gardam Screeningtb

download Monday Gardam Screeningtb

of 13

Transcript of Monday Gardam Screeningtb

  • 8/12/2019 Monday Gardam Screeningtb

    1/13

    1

    Screening for

    Tuberculosis

    Screening for

    Tuberculosis

    Michael Gardam

    TB Clinic,

    Toronto Western Hospital

    Annual risk is not constant

    Riskofdevelopingactivedisease

    Years after exposure

    High Risk PeriodHigh Risk Period

  • 8/12/2019 Monday Gardam Screeningtb

    2/13

    2

    Risk factors for infection

    Exposure Risk factors

    Born in high-risk country

    Occupation (e.g.healthcare worker)

    Serious travel to high-risk country

    Close contact of known active case

    Age

    Immunosuppression (HIV)

    Estimated new TB cases (all

    forms) per 100 000 population

    No estimate

    0-24

    50-99

    300 or more

    25-49

    100-299

    Risk factors for progression

    Canadian Standards, 2008

  • 8/12/2019 Monday Gardam Screeningtb

    3/13

    3

    nfection versus !isease

    Latent Infection Active Disease

    Burden oforganisms

    Low Low-High

    Symptoms None None-florid

    Transmissibility Never infectious Often infectious ifpulmonary

    Mantoux Usually positive Often positive

    CXR 95% normal May be abnormal,Infiltrates, cavities

    Therapy Optional preventativetherapy

    4 drugs pendingsensitivities

    TB screening

    Warning: skin testing can be confusing"

  • 8/12/2019 Monday Gardam Screeningtb

    4/13

    4

    Screening guidance

    #nl$ screen if $ou plan on doing something%ith the results

    f looking for infection or disease, onl$ screen

    those that ha&e a reason to be infected

    Screening lo% pre&alence populations %ill result in

    a high proportion of false positi&e results

    Screening modalities

    Chest radiograph screening detects'

    (cti&e pulmonar$ disease

    Those at high risk of de&eloping acti&e disease

    Will miss most people with latent infection

    Tuberculin skins testing and Interferon

    Gamma Release Assays (IGRAs detect'

    )atent infection

  • 8/12/2019 Monday Gardam Screeningtb

    5/13

    5

    Purified Protein !eri&ati&e

    aka PP!, Tuberculin

    !ifferent formulations used Contains appro*imatel$ + antigens

    Man$ antigens are shared bet%een differentm$cobacteria

    M tuberculosis comple*

    M bovis

    !CG strain of M bovis

    -n&ironmental m$cobacteria

    Contraindications

    Se&ere reactions in

    the past

    Pre&ious documented

    positi&e

    -*tensi&e skin disease

    Recent significant

    &iral illness

    "ot Contraindications

    Pregnanc$

    Recent &accination %itha killed &accine

    BCG &accination histor$

    Pre&iousl$ positi&e butnot documented

    Children

    Ho% to read a test

    Measure induration using the pen techni.ue

    n Canada' trans&erse diameter

    n the /S, a&erage of the longitudinal and

    trans&erse diameters

    0 1mm is positi&e if'

    2no%n recent contact

    Significantl$ immunocompromise

    Has fibronodular disease on their chest film

    0 3 mm is positi&e for e&er$bod$ else

  • 8/12/2019 Monday Gardam Screeningtb

    6/13

    6

    Tuberculin skin test measurement

    nterobser&er &ariabilit$ 4+51 mm6 ntra7obser&er &ariabilit$ 43587359 mm6

    Biologic &ariabilit$ 4:8mm6

    A change in up to #mm between tests can

    $ust be due to %ariability&

    Sensiti&it$ and specificit$

    Sensiti&it$ cited as 9;< for latent TBinfection in health$ indi&iduals

    !ecreased in immunocompromised

    Sensiti&it$ closer to ;< for acti&edisease

    Specificit$ influenced b$ BCG&accination, other m$cobacterial

    e*posure

    Boosting

    #ccurs %ith remote BCG, at$pical

    m$cobacteria, M. tuberculosis e*posure

    Common 4178

  • 8/12/2019 Monday Gardam Screeningtb

    7/13

    7

    (ge at BCG &accination

    and positi&e TSTs

    nfanc$' no difference in positi&it$ bet%een&accinated and un&accinated after 1 $ears

    Primar$ school' 317+1< remain positi&e after

    3 $ears

    nduration = 3>mm unlikel$ to be BCG

    Iseman, 2000

    18mm

    Wh$ + step tests?

    Perform a + step if'

    @ou plan on testing the person again e5g5 atthe time of first hire

    @ou %ant to increase the sensiti&it$ as muchas possible

  • 8/12/2019 Monday Gardam Screeningtb

    8/13

    8

    Con&ersion

    !ifferent definitions'A mm' more sensiti&e, less specific

    Ma$ be difficult to interpret gi&en &ariabilit$

    3 mm' more specific, less sensiti&e

    Best interpreted in conunction %ithepidemiolog$

    e5g5, healthcare %orker in contact %ith acti&e case

    Michael Gardam April 27,2005

    Re&ersion

    /p to >< of positi&e adults %ill becomenegati&e on repeat testing

    More common in adults

    More common in those %ith moderate siedinduration

    More common in those %ith boosting -speciall$ if boosted after 8 or more serial tests

    'ninterpretabletry not to retest

    Summar$

    Reading and interpreting skin tests is not so

    simple5

    This %as supposed to be fi*ed b$ nterferon

    Gamma Release (ssa$s

  • 8/12/2019 Monday Gardam Screeningtb

    9/13

    9

    nterferon Gamma Release (ssa$s

    4GR(s6

    DE7based tests

    Gardam et.al. Lancet ID

    nterferon7gamma release assa$s

    4GR(s6

    FuantiE-R#D Gold

    -)S(

    T7Spot5TB

    -)SP#T

  • 8/12/2019 Monday Gardam Screeningtb

    10/13

    10

    (ntigens used in latest GR(s

    T%o M. tuberculosis proteins are used in theassa$s'

    -arl$ secreted antigenic target 4-S(T7A6

    Culture filtrate protein 3 4CEP736

    Compare %ith =+ antigens in Tuberculin

    Specific antigens for TB?

    -S(T7A and CEP73 are also found in'

    M. leprae

    Wild t$pe M. bovis 4not the BCG strains6

    M. marinum

    M. kansasii

    M. szulgai

    M. flavescens

    Reasonably common

    in Canada

    (d&antages of GR(s

    More specific than the TST 4dont react to BCG

    and most other non7TB m$cobacteria6

    #nl$ 3 &isit re.uired

    Do boosting phenomenon T7Spot5TB is more sensiti&e than the TST in

    immunocompromised

  • 8/12/2019 Monday Gardam Screeningtb

    11/13

    11

    Hemodial$sis patients

    Passalent et. al., CJASN 2006

    !isad&antages

    Same general issues as the TST in

    immunocompromised i5e5 the$ dont %ork as

    %ell

    -*pensi&e, often patients must pa$ for them

    )imited a&ailabilit$

    Ha&e same issues %ith re&ersion as the TST

    The risk of de&eloping acti&e TB in the settingof a positi&e GR( is unclear

    !iscordant results

    TST , GR( I

    Secondar$ to BCG or false negati&e GR(?

    TST 7, GR(

    Poor sensiti&it$ of the TST or false positi&e GR(?

    )ou cannot tell with certainty

  • 8/12/2019 Monday Gardam Screeningtb

    12/13

    12

    !iscordant results in lo% risk, BCG

    &accinated population

    !iscordant results in moderate or high

    risk, BCG &accinated populations

    GR( Summar$

    (t present, the role for GR(s is relati&el$limited

    testing lo% risk populations %ho ha&e recei&edBCG

    mmunocompromised populations 4T7Spot5TB6

    TST is generall$ the preferred test in Canada

    Conclusions

    Chest radiograph screening is best as an initial

    assessment for pulmonar$ TB

    TSTs and GR(s are best for detecting latent

    infections

    nterpreting TSTs is complicated

    GR(s ha&e some ad&antages but are not

    panaceas

  • 8/12/2019 Monday Gardam Screeningtb

    13/13

    13

    michael5gardamJuhn5ca